Page last updated: 2024-09-05

sb 216763 and Atrophy, Muscle

sb 216763 has been researched along with Atrophy, Muscle in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baarsma, HA; de Theije, CC; Gosens, R; Haegens, A; Langen, RC; Pansters, NA; Remels, AH; Schols, AM; Verhees, KJ	1

Other Studies

1 other study(ies) available for sb 216763 and Atrophy, Muscle

Article	Year
Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: II. Effects on skeletal muscle atrophy. Respiratory research, 2013, Nov-01, Volume: 14 Topics: Animals; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Glucocorticoids; Glycogen Synthase Kinase 3; Guinea Pigs; Indoles; Lipopolysaccharides; Male; Maleimides; Muscle Development; Muscle, Skeletal; Muscular Atrophy; Pulmonary Disease, Chronic Obstructive; Tumor Necrosis Factor-alpha	2013

Article

Year

Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: II. Effects on skeletal muscle atrophy.

Respiratory research, 2013, Nov-01, Volume: 14

Topics: Animals; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Glucocorticoids; Glycogen Synthase Kinase 3; Guinea Pigs; Indoles; Lipopolysaccharides; Male; Maleimides; Muscle Development; Muscle, Skeletal; Muscular Atrophy; Pulmonary Disease, Chronic Obstructive; Tumor Necrosis Factor-alpha

2013